Ocean Optics Names Winner of 2016 Young Investigator Award

17-Mar-2016 - USA

Ocean Optics recently named Wentao Wang from Florida State University the winner of the 2016 Ocean Optics Young Investigator Award.

The Young Investigator Award is presented to a researcher who is a graduate student or has completed their graduate work in the last five years and is the primary author of the best juried paper submitted as part of the “Colloidal Nanoparticles for Biomedical Applications XI” conference at the 2016 BiOS/Photonics West Symposium. The honor includes a $1,000 investigator award and a $2,000 company grant to the lab where the work was performed.

Wang was honored for the paper titled “Design of a multi-coordinating polymer as a platform for functionalizing metal, metal oxide and semiconductor nanocrystals,” coauthored by Xin Ji (Florida State University), Ocean Nanotech, LLC, Anshika Kapur (Florida State University), and advisor Dr. Hedi Mattoussi (Florida State University). The award was presented by Dr. David Creasey, Vice President of Sales and Marketing for Ocean Optics, and Colloidal Nanoparticles for Biomedical Applications conference co-chairs Dr. Wolfgang Parak (Philipps-Univ. Marburg) and Dr. Marek Osinski (The Univ. of New Mexico).

The paper “Comparison of Fe2O3 and Fe2CoO4 core-shell plasmonic nanoparticles for aptamer mediated SERS assays,” by Haley Marks (Texas A&M University) and advisor Dr. Gerard L. Coté, was recognized as runner up.

Ocean Optics has sponsored the Young Investigator Award since 2005 and has long supported young scientists from around the world through sponsorships, grant programs and partnership.

“Ocean Optics spectroscopic technologies are well suited to biomedical applications, where measurement flexibility is valued,” said Ocean Optics’ Creasey. “It’s very exciting for us to collaborate with researchers at the forefront of new developments in nanotechnology and life sciences applications.”

Other news from the department science

Most read news

More news from our other portals

So close that even
molecules turn red...

Last viewed contents

Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials - New Patent Broadens Company’s Existing Protection of Optimized RNAi Molecules Including Proprietary AtuRNAi Platform

Biofrontera received official review of its drug approval dossier for BF-200 ALA

Acambis extends Sanofi Pasteur licensing agreement on single-dose JE vaccine to India and Indian subcontinent

Exiqon A/S wins prestigious Ernst & Young Entrepreneur of the Year Award

Bio-Rad Announces Receipt of New Ruling in Applied Biosystems Patent Infringement Dispute

Sandoz completes acquisition of EBEWE Pharma, improving global patient access to affordable injectable cancer medicines - Sandoz to focus on quick and seamless integration for customers and employees

Eckert & Ziegler acquires Vitalea Science Inc. as Part of Strategic Move into Innovative Pharmaceutical Services

Albumin preserves kidney function and improves survival in abdominal infection of liver disease

Transition Therapeutics Announces Appointment of Vice-President of Clinical Operations

UCB to sell its U.S. specialty generics business Kremers Urban for US$ 1,525 million

Evotec and Novo Nordisk form research alliance in diabetes and obesity

CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema - Phase I/II study to establish safety and clinical pharmacology with various doses of subcutaneous formulation of human C1-esterase inhibitor